# Novopain

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/novopain

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.novopain.com/
- Total disclosed funding: $3M
- Latest round: Angel (Sep 1, 2026)
- Investors on record: 2

## About

Based in Beijing, China and founded in 2025, Beijing Zhuozhi Medical Technology Co., Ltd., trading as Novopain, is a provider of comprehensive pain management solutions. In September 2026, Novopain raised CNY 20 million in Angel funding led by Zhongguancun Development Venture, with participation from Shanghai Changyao Shengbo Medical Technology Co., Ltd.

The company focuses on the objective, quantitative assessment of pain and the development of diagnosis and treatment protocols. It utilizes EEG signal acquisition and decoding algorithms to achieve precise pain measurement and employs neuromodulation technologies, such as non-invasive spinal cord stimulation, to implement closed-loop interventions.

The company's revenue is generated by providing comprehensive pain management solutions.

The company will use the funding for the research and development and iteration of core technology platforms such as dedicated EEG and related signal acquisition hardware, non-invasive spinal cord stimulation hardware, decoding algorithms and application software, and will also support multi-center clinical research.

## Funding rounds

- Angel, Sep 1, 2026, $3M — Zhongguancun Development Venture, Shanghai Changyao Shengbo Medical Technology Co., Ltd.

## Investors

- Zhongguancun Development Venture (https://capitalatlas.ai/funds/zhongguancun-development-venture) — Angel
- Shanghai Changyao Shengbo Medical Technology Co., Ltd. — Angel